Portugal Lawyer Joana Silveira Botelho provides regular legal assistance to pharmaceutical companies and other entities of the health sector. Here she examines Portugal’s new regulatory framework on cannabis for medicinal purposes.    What will actually change considering that in Portugal (and in the European Union) it is already possible to obtain a marketing…

Opinion Mohamed is a passionate Blockchain enthusiast who is committed to helping grow the Blockchain ecosystem around the world. Here he talks about healthcare’s slow adoption of technology and the challenges that come with hefty privacy regulation of patient data.  The life-and-death nature of the industry might be a factor of…

Mexico Cristobal Thompson is the Executive Director at AMIIF (Asociacion Mexicana de Industrias de Investigacion Farmaceutica). The AMIIF represents more than 60 global companies with the aim of contributing to improving health in Mexico through innovative medicine. Here Cristobal discusses Mexico’s regulatory landscape and the countries advances in healthcare.    Mexico has…

Karim Babay is Chairman & CEO of HealthSapiens, a nationwide healthcare provider that delivers on-demand access to healthcare anytime, anywhere, via mobile devices, the internet, video and phone. Here he discusses the need for more price transparency within healthcare systems so that consumers can make informed choices that save them…

Opinion Richard Saynor, Senior Vice President, Classic and Established Products at GSK urges big pharma to weigh in on improving global health and well-being to achieve the United Nations Sustainable Development Goals.  On the part of pharmaceutical companies, we have a responsibility to help people gain access to high-quality healthcare and…

Innovation Joonho J. Lee is a CEO and CoFounder of Cognita Lab INC developing risk management framework around Artificial Intelligence (AI) in healthcare and financial services industries. Here he discusses the use of blockchain in the healthcare industry and the need to remain “cautiously optimistic.”   Many people asked whether I…

Digital Health Rhenu Bhuller, a founding member of Frost & Sullivan’s Asia Pacific operations and expert in analysing the impact of cutting-edge tech, looks at pharma’s evolution and adoption of digital health.   The evolution of disease management and the convergence of drugs, devices and digital health in the management of various…

Innovation Meghann Chilcott, Senior Vice President of OrderInsite, looks at how new technology is being applied to improve accuracy and efficiency in pharmacy accounting. The Centers for Medicare and Medicaid Services put the cost of billing and payment errors in 2017 at $36.21 billion. Pharmacy accounting and bookkeeping is a challenging necessity.…

Innovation Carla Smith, Executive Vice President of The Healthcare Information and Management Systems Society (HIMSS) discusses the need to adopt innovation and retrain the workforce to provide healthcare without walls. If we are short-sighted and base our future workforce projections upon outdated models, we will experience a significant shortage in the…

Canada Brian Hilberdink, President of Novo Nordisk Canada, calls for collaboration between government and industry to ensure that Canadian patients get swift access to the best treatments.    As a Canadian who spent several years working globally for a biopharmaceutical company, I saw firsthand how pricing and investment decisions can be made…

USA David H. Crean, PhD, Managing Director for Objective Capital Partners, a leading investment banking advisory firm examines the healthcare market for 2018.     Following a decade high of VC invested in 2017, and on a record pace again in 2018, valuations continue to move higher across all stages within…

UK Aditya Bhattacharji manages Eurasia Group‘s healthcare analysis. In his second piece for PharmaBoardroom, Aditya examines the dangers of nationalism and populism for the private sector.   The biggest global risk I see is with active pharmaceutical ingredients, most of which come from China, which has been at the centre of trade tensions,…